DNMT3A and myelodysplastic syndrome: While a causal role for TET2 and DNMT3A mutations is likely given that they are some of the most frequently mutated genes found in pre-LSC of AML and MDS patients, how exactly these mutations lead to leukemogenesis is still far from understood.